May 05, 2026
Medically Reviewed by Dr. Sunita Tandulwadkar | Written by ALIV
The most common question first-time patients ask at ALIV's Pune and Mumbai clinics is not "will this work?" — it is "what will I feel?" That is a sensible question to ask before anything goes into your vein. IV therapy is a clinical procedure. The body notices it. Understanding which sensations are expected and benign — and which ones require your nurse's immediate attention — makes the experience both safer and less anxiety-inducing.
The straightforward summary: the large majority of IV sessions at ALIV are uneventful. Patients feel mild sensations during infusion, nothing alarming during monitoring, and leave feeling better than they came. But there are specific things to know.
Coolness at the insertion site and up the arm. IV fluids are administered at room temperature, which is below body temperature. A mild coolness travelling up the forearm from the cannula site during the first few minutes of infusion is universal and entirely benign. It typically fades within five to ten minutes as the fluid warms to body temperature. Some patients describe it as pleasant, particularly in a warm room.
The niacin flush. This is the one that catches first-time patients off guard most reliably. High-dose vitamin B3 (niacin) — present in most Myers' Cocktail formulations — produces a characteristic flush: a warm, tingling, sometimes prickly sensation that usually starts on the face and neck and can spread to the chest and upper body. It looks red. It feels warm and strange. It is not an allergic reaction. It is a predictable vasodilation response to niacin at doses above the flush threshold. It peaks around 15 minutes and subsides on its own. At ALIV, every patient who will receive B-vitamin-containing formulations is warned about this before the session starts. If a clinic has never mentioned the niacin flush to you, that is a gap in their patient communication.
Mild metallic taste. Some patients notice a brief metallic taste during infusion — more common with mineral-heavy formulations containing zinc or magnesium. It passes within a few minutes and indicates nothing concerning.
Mild pressure or fullness at the IV site. A subtle sense of pressure around the cannula is normal. What is not normal is pain, stinging, or a sensation that worsens with time — which we address below.
Brief mild lightheadedness. Some patients feel mildly lightheaded in the first five to ten minutes of infusion, often related to the vasodilating effects of magnesium causing a slight blood pressure drop. Mention it immediately — slowing the infusion rate resolves this in almost every case.
Pain or burning at the cannula site. If you feel a stinging, burning, or increasingly painful sensation at the insertion site — especially if the area begins to swell or feel puffy and boggy — the cannula has likely infiltrated. This means it has shifted out of the vein and is delivering fluid into the surrounding tissue. It is uncomfortable but not dangerous. Tell your nurse immediately so the cannula can be repositioned. Do not sit through escalating pain hoping it improves.
Sustained chest tightness or palpitations. A brief, passing sensation of chest heaviness — particularly with magnesium-containing formulations — is manageable and typically rate-dependent. A sustained, worsening sensation, irregular heartbeat, or any chest pain of any quality should be communicated immediately. The infusion is slowed or stopped and a proper assessment is done. At ALIV, this is standard protocol, not an overreaction.
Significant nausea. Nausea during infusion is usually rate-dependent — most common with NAD+ IV and certain zinc-containing formulations when administered too quickly. The solution is slowing the infusion, not pushing through. Tell your nurse as soon as nausea begins, not when it has become severe.
Allergic reactions to IV therapy ingredients are uncommon — but they can occur, even with ingredients you have had before. Signs of an allergic response include: hives or a spreading rash, throat tightening, difficulty breathing, or sudden significant dizziness. At ALIV, every clinical session has adrenaline (epinephrine) and resuscitation equipment immediately accessible and nursing staff trained in emergency response. This is not optional safety equipment — it is the clinical minimum for any setting performing IV therapy.
Minor bruising at the cannula site is common and resolves within two to three days. Mild soreness at the site for 12 to 24 hours after is normal. What warrants contacting your clinic: spreading redness, warmth, swelling, or any discharge from the site more than 24 hours after the session. These suggest phlebitis or localised infection — both uncommon and both manageable when caught early.
No. The niacin flush is one of the most predictable and consistently harmless responses in IV therapy. It is caused by prostaglandin-mediated vasodilation — the blood vessels near the skin dilate briefly. It is uncomfortable for some patients and surprising for almost everyone who has not been warned. It is not an allergic reaction and does not require any intervention beyond knowing it will pass. Aspirin taken 30 minutes before the session can reduce the flush for patients who find it particularly bothersome — ask your ALIV doctor.
The most common cause is arriving dehydrated — changes in blood osmolality as fluid rapidly enters a dehydrated system can trigger a mild headache. Hyperosmolar formulations infused too quickly can also cause a transient headache in sensitive individuals. Pre-session hydration (two to three litres of water the day before) prevents this in most cases.
Tell your nurse immediately — do not wait to see if the sensation resolves. At ALIV, the nursing team is trained to assess and manage every common IV therapy response in real time. The infusion can be slowed, paused, or stopped depending on what you are experiencing.
Repeated IV access in the same vein over time can cause mild phlebitis — inflammation and scarring of the vein wall. At ALIV, vein sites are rotated across sessions, proper cannula technique is used, and patients are monitored for signs of site irritation.
Yes — needle anxiety is very common and is routinely managed at ALIV's Pune and Mumbai clinics. Breathing techniques, reclined positioning, and having a companion present during the session all help. The cannula insertion itself is brief.
ALIV's clinical team in Pune and Mumbai is transparent about every sensation and manages every response in real time. You will not be left alone wondering what is happening. Visit alivtherapy.in to book your session.
Medically Reviewed by Dr. Sunita Tandulwadkar. This article is for informational purposes only and does not constitute medical advice. Therapies offered by ALIV are proprietary, experimental protocols and results vary by individual.